Citi Research Report: Citi Research has initiated a 30-day positive catalyst watch on MAOYAN ENT (01896.HK) due to the upcoming release of the animated movie Demon Slayer on November 14, which it will distribute.
Box Office Performance: The film has already achieved significant global success, ranking fifth worldwide with over US$677 million and becoming the top international movie in North America.
Popularity Metrics: The announcement of Demon Slayer has led to a surge in interest, with Maoyan Pro recording over 400,000 'to-watch' clicks in just one day.
Investment Outlook: Citi Research maintains a Buy rating for MAOYAN ENT, setting a target price of $9.3 based on a 14x adjusted EPS for 2026, anticipating that box office success during the New Year holiday will positively impact the company.
Wall Street analysts forecast 01896 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 01896 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast 01896 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 01896 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 7.250
Low
Averages
High
Current: 7.250
Low
Averages
High
Citi Research
Buy
maintain
$9.3
Al Analysis
2025-11-05
Reason
Citi Research
Price Target
$9.3
Al Analysis
2025-11-05
maintain
Buy
Reason
The analyst rating from Citi Research for MAOYAN ENT (01896.HK) is based on several key factors:
1. Upcoming Movie Release: The scheduled release of the animated movie "Demon Slayer" on November 14, for which MAOYAN ENT is the distributor, is expected to drive significant box office performance.
2. Strong Global Performance: The movie has already shown robust global box office results, ranking fifth worldwide with over US$677 million, and has become the top international movie in North America.
3. High Demand Indicators: The announcement of the movie has generated considerable interest, as evidenced by over 400,000 'to-watch' clicks recorded on Maoyan Pro within a single day.
4. Holiday Season Impact: With the New Year holiday period starting in late November, any box office outperformance is anticipated to positively impact MAOYAN ENT, given its position as the largest ticketing platform.
5. Target Price and Valuation: Citi Research maintains a Buy rating with a target price of $9.3, based on a 14x adjusted EPS for 2026, indicating confidence in the company's future earnings potential.
These factors collectively contribute to the positive catalyst watch and the Buy rating for MAOYAN ENT.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
